IP Library Granted Patent US 11,841,327
Granted Patent B2
US 11,841,327 · App. 17/157,080 · Granted Dec 12, 2023

Detection and characterization of defects in pharmaceutical cylindrical containers

Inventor: Daniel Willmes (Langrickenbach, CH)
Assignee: SCHOTT PHARMA SCHWEIZ AG
G01N21/892G01N21/8901G01N21/8914G01N2021/8905
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,841,327
App. No.
17/157,080
Granted
Dec 12, 2023
Kind
B2
Abstract

An apparatus for inspecting a pharmaceutical cylindrical container made of a polymer, a specific method for inspecting a pharmaceutical cylindrical container made of a polymer and a specific bundle of pharmaceutical cylindrical containers made of a polymer.

Claims (39)

1. An apparatus for inspecting a pharmaceutical cylindrical container made of a polymer and detecting slides in the polymer, comprising:

a support device configured to support the pharmaceutical cylindrical container and rotate the cylindrical pharmaceutical container around a longitudinal axis;

a light emitting unit comprising a light source configured to illuminate the pharmaceutical cylindrical container with an inspection beam having a wavelength from 100 nm to 400 nm to stimulate photoluminescence of the of the pharmaceutical cylindrical container; and

a light receiving unit that is configured to detect slides in the polymer, the light receiving unit comprising a filter that blocks light having a wavelength of 600 nm or more and a camera that receives light emitted by the pharmaceutical cylindrical container due to the photoluminescence and acquires an image of the pharmaceutical cylindrical container,

wherein the polymer is a cycloolefin copolymer (COC) or a cycloolefin polymer (COP).

2. The apparatus of claim 1 , wherein the support device, the light emitting unit, and the light receiving unit are configured to inspect the pharmaceutical cylindrical container in one second or less.

3. The apparatus of claim 1 , wherein the light source emits light comprising a wavelength from 220 nm to 380 nm.

4. The apparatus of claim 1 , wherein the light source is a source selected from a group consisting of an ultraviolet gas-discharge lamp, an ultraviolet light-emitting diode, an ultraviolet laser, an ultraviolet light-emitting diode, an ultraviolet laser, and combinations thereof.

5. The apparatus of claim 1 , wherein the light receiving unit is configured to receive light emitted by the pharmaceutical cylindrical container having a wavelength in a range selected from a group consisting of 300 nm to 700 nm, 400 nm to 500 nm, and 430 nm to 460 nm.

6. The apparatus of claim 1 , wherein in the support device, the light emitting unit, and the light receiving unit are configured so that X=B−A,

wherein B is a wavelength of the light emitted by the pharmaceutical cylindrical container at a maximum, and

wherein A is a wavelength emitted by the light source of the light emitting unit at a maximum, and

X is in distance in a range selected from a group consisting of 50 nm to 500 nm, 75 nm to 500 nm, and 100 nm to 300 nm.

7. The apparatus of claim 1 , wherein the light receiving unit further comprises a lens, wherein the lens is permeable for light having a wavelength in a range selected from a group consisting of 200 nm to 900 nm, 400 nm to 800 nm, 400 nm to 500 nm, and 430 nm to 460 nm.

8. The apparatus of claim 1 , wherein the light receiving unit further comprises a filter, wherein the filter blocks light having a wavelength of 600 nm or more and/or a wavelength of 200 nm or less.

9. The apparatus of claim 1 , wherein the support device supports the pharmaceutical cylindrical container so that the longitudinal axis and a horizontal axis perpendicular to the longitudinal axis define a horizontal plane, and wherein the camera has a centerline that intersects the horizontal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less.

10. The apparatus of claim 1 , wherein the support device supports the pharmaceutical cylindrical container so that the longitudinal axis and a vertical axis perpendicular to the longitudinal axis define a vertical plane, and wherein the camera has a centerline that intersects the vertical plane at an angle of 60° or more and 90° or less, 70° or more and 90° or less, and 80° or more and 90° or less.

11. The apparatus of claim 1 , wherein the support device supports the pharmaceutical cylindrical container so that a horizontal axis perpendicular to the longitudinal axis and a vertical axis perpendicular to the longitudinal axis intersect a middle of a cylindrical part of the pharmaceutical cylindrical container at a transversal plane, and wherein the camera has a centerline that intersects the transversal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less.

12. The apparatus of claim 1 , wherein the inspection beam comprises unpolarized light.

13. A method for inspecting a pharmaceutical cylindrical container made of a cycloolefin copolymer (COC) or a cycloolefin polymer (COP), comprising:

illuminating the pharmaceutical cylindrical container with a first light emitting unit;

receiving light emitted by the pharmaceutical cylindrical container with a light receiving unit to acquire a first image of the pharmaceutical cylindrical container;

receiving light scattered by and/or transmitted through the pharmaceutical cylindrical container with the first light receiving unit or a second light receiving unit to acquire a second image of the pharmaceutical cylindrical container; and

characterizing defects in and/or on the pharmaceutical cylindrical container based on a comparison of the first image showing emitted light and the second image showing scattered and/or transmitted light

analyzing the defects to identify slides in the COC or COP of the pharmaceutical cylindrical container.

14. The method of claim 13 , further comprising:

illuminating the pharmaceutical cylindrical container with a second light emitting unit, the second light emitting unit having a different wavelength, intensity, size, and/or polarization of emitted light than the first light emitting unit.

15. The method of claim 13 , wherein the second image is acquired by receiving light scattered by and/or transmitted through the pharmaceutical cylindrical container with the second light receiving unit.

16. The method of claim 13 , further comprising controlling a process of manufacturing the pharmaceutical cylindrical container based on identified slides in the COC or COP of the pharmaceutical cylindrical container.

17. The method of claim 13 , further comprising disregarding, based on the first image and/or second image, any pharmaceutical cylindrical container exhibiting a value of Y and/or Z of 0.05 to 1.0,

wherein Y=A1/B1,

wherein A1 is a maximum length in cm of any slide in a cylindrical part of the pharmaceutical cylindrical container,

wherein B1 is a length in cm of the cylindrical part of the pharmaceutical cylindrical container,

wherein Z=A2/B2,

wherein A2 is an area in cm 2 of any slides, and

wherein B2 is an area in cm 2 of the cylindrical part.

18. The method of claim 17 , wherein the value of Y and/or Z is 0.5 to 1.0.

19. The method of claim 17 , wherein the value of Y and/or Z is 0.05 to 1.0.

20. The method of claim 13 , wherein the illuminating, receiving, and characterizing defects steps for each pharmaceutical cylindrical container are completed in 1 second or less.

Assignments (2)
CHANGE OF NAME Recorded Nov 7, 2022
From: SCHOTT SCHWEIZ AG
To: SCHOTT PHARMA SCHWEIZ AG
Reel/Frame 061895/0026 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: WILLMES, DANIEL, MR.
To: SCHOTT SCHWEIZ AG
Reel/Frame 055364/0092 →
Priority Claims (1)
EP 20153330 · Jan 23, 2020 · regional
Continuity (1)
Related Publication 20210231576A1 · Jul 29, 2021